India is among the most attractive markets for GLP-1 drugs, driven by rising obesity and diabetes prevalence
Behavioral programs layered on top of the medication can make that long game more sustainable
Therefore, its always advisable to consult with healthcare professionals or dietitians who can provide tailor-made advice, considering both your health goals and the effects of semaglutide
Dulaglutides safety profile is consistent with other GLP-1 receptor agonists, with transient nausea being the most frequently reported adverse event (14.6% incidence). Dose escalation from 0.75 to 1.5 mg is recommended after at least four weeks, based on individual glycemic control needs [57]
The long half-life maintains therapeutic levels between injections
I felt very safe and at ease in the hands of Dr Gad, I would definitely recommend him